Harm reduction for injecting opiate users: An update and implications in China

Acta Pharmacologica Sinica

Volumn 30, Issue 5, 2009, Pages 513-521

  Meise, Maja ^a,b   Wang, Xi ^a   Sauter, Marie Luise ^a,b   Bao, Yan Ping ^a   Shi, Jie ^a   Liu, Zhi Min ^a   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Drug addiction; Harm reduction; HIV; Injecting opiate users

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BUPRENORPHINE; DIAMORPHINE; DIHYDROCODEINE; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUSTRALIA; CHINA; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DRUG COST; DRUG MECHANISM; EPIDEMIC; EUROPE; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; NEEDLE; NORTH AMERICA; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT COUNSELING; PEER GROUP; REVIEW; SELF HELP; SUBSTITUTION THERAPY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHINA; EUROPE; HARM REDUCTION; HUMANS; METHADONE; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; PEER GROUP; SELF ADMINISTRATION; SELF-HELP GROUPS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 66749113088     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.30     Document Type: Review

References (44)

1. Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Br J Gen Pract 2005; 55: 139-46.
2. Joint United Nations Programme on HIV/AIDS. 2006 Report on the global AIDS epidemic. Geneva: UNAIDS; 2006.
3. Ball AL. HIV, injecting drug use and harm reduction: a public health response. Addiction 2007; 102: 684-90.
4. Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol 2001; 154 (12 suppl): S70-7.
5. Des Jarlais DC, Friedman SR, Ward TP. Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health 1993; 14: 413-50.
6. European Monitoring Centre for Drugs and Drug Addiction. Drugs in focus: key role of substitution in drug treatment. Luxembourg: Office for Official Publications of the European Communities; 2002.
7. World Health Organization, United Nations Office on Drugs and Crime. Joint United Nations Programme on HIV/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: World Health Organization; 2004.
8. Kimber J, Dolan K, Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug Alcohol Rev 2005; 24: 21-4.
9. Cruz MF, Patra J, Fischer B, Rehm J, Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy 2007; 18: 54-61.
10. Hedrich D. European report on drug consumption rooms. Luxembourg: Office for Official Publications of the European Communities; 2004.
11. Michels II, Stover H, Gerlach R. Substitution treatment for opioid addicts in Germany. Harm Reduct J 2007; 4: 5.
12. Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18: 2295-303.
13. Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, et al. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention. Int J Drug Policy 2007; 18: 204-12.
14. O'Hare PA. The reduction of drug related harm. London: Routledge; 1992.
15. Wodak A, Cooney A. Efectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2004.
16. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353: 221-6.
17. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28: 321-9.
18. Shi J, Zhao L, Epstein D, Zhao C, Shuai Y, Yan B, et al. Te efect of methadone maintenance on HIV and HCV infection, health status, employment, and criminal activity among heroin abusers during six months of treatment in China. J Addict Med 2007; 1: 186-90.
19. Kraf MK, Rothbard AB, Hadley TR, McLellan AT, Asch DA. Are supplementary services provided during methadone maintenance really cost-efective? Am J Psychiatry 1997; 154: 1214-9.
20. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, bupre-norphine, and methadone for opioid dependence. N Engl J Med 2000; 343: 1290-7.
21. Trautmann F, Barendregt C. Te European peer support manual: peer support as a method for AIDS prevention in injecting drug user communities. Utrecht: NIAD; 1994.
22. Fang YX, Wang YB, Shi J, Liu ZM, Lu L. Recent trends in drug abuse in China. Acta Pharmacol Sin 2006; 27: 140-4.
23. Michels I, Zhao M, Lu L. Drug abuse and its treatment in China. German J Addict 2007; 53: 228-37.
24. Lu L, Fang Y, Wang X. Drug abuse in China: past, present and future. Cell Mol Neurobiol 2008; 28: 479-90.
25. UNAIDS Asia Pacifc Intercountry Team, United Nations International Drug Control Programme, Regional Centre for East Asia and the Pacifc. Drug use and HIV vulnerability: policy research study in Asia. Bangkok: Joint United Nations Programme on HIV/AIDS; 2000.
26. Li XJ, Kusagawa S, Xia X, Yang C, Wang Q, Yokota Y, et al. Molecular epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan Province of China suggests origin from the local IDU epidemic. AIDS Res Hum Retroviruses 2005; 21: 977-80.
27. Fengrui Y. Annual Report on Drug Control in China. Beijing: National Narcotics Control Commission; 2006.
28. Li X, Zhou Y, Stanton B. Illicit drug initiation among institutionalized drug users in China. Addiction 2002; 97: 575-82.
29. State Council AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China (2004). Beijing: State Council AIDS Working Commitee Ofce, UN Teme Group on AIDS in China; 2004.
30. Ministry of Health of China, National Center for AIDS Prevention and Control, Collaboration Group for National HIV Sentinel Surveillance Program. Set up of national sentinel surveillance of HIV infection in China and its report in 1995. Zhongguo Xing Bing Ai Zi Bing Fang Zhi 1996; 2: 193-7.
31. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci 2004; 1025: 446-57.
32. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007; 369: 679-90.
33. Ministry of Health, Joint United Nations Programme on HIV/ AIDS, World Health Organization. 2005 update on the HIV/ AIDS epidemic and response in China. Beijing: National Center for AIDS/STD Prevention and Control, China CDC; 2006.
34. Lu L, Wang X. Drug addiction in China. Ann N Y Acad Sci 2008; 1141: 304-17.
35. Qian HZ, Vermund SH, Wang N. Risk of HIV/AIDS in China: subpo pulations of special importance. Sex Transm Infect 2005; 81: 442-7.
36. Tang YL, Zhao D, Zhao C, Cubells JF. Opiate addiction in China: current situation and treatments. Addiction 2006; 101: 657-65.
37. Sullivan SG, Wu Z. Rapid scale up of harm reduction in China. Int J Drug Policy 2007; 18: 118-28.
38. Open Society Institute, International Harm Reduction Association. Harm reduction developments 2005: countries with injection-driven HIV epidemics. New York: Open Society Institute; 2006.
39. Humeniuk R, Ali R. Te frst methadone clinic in Beijing. Drug Alcohol Rev 2005; 24: 285-7.
40. Kosten TR, Gardner TJ. China's new march forward in addiction treatment: methadone for the masses: 2. Issues in formulating DSM V. Am J Drug Alcohol Abuse 2008; 34: 123-6.
41. Chen HT, Liao Q. A pilot study of the NGO-based relational intervention model for HIV prevention among drug users in China. AIDS Educ Prev 2005; 17: 503-14.
42. Wu Z, Sun X, Sullivan SG, Detels R. Public health: HIV testing in China. Science 2006; 312: 1475-6.
43. Walker R. Gates Foundation commits to expansion of HIV prevention in China. AIDS Portal [http://www.aidsportal.org/ News-Details.aspx?ID=6337; accessed December 24, 2008].
44. Tang YL, Wiste A, Mao PX, Hou YZ. Atitudes, knowledge, and perceptions of Chinese doctors toward drug abuse. J Subst Abuse Treat 2005; 29: 215-20.